Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana

Detalhes bibliográficos
Autor(a) principal: Florimond, Celia
Data de Publicação: 2023
Outros Autores: de Laval, Franck, Early, Angela M, Sauthier, Swaélie, Lazrek, Yassamine, Pelleau, Stéphane, Monteiro, Wuelton M, Agranier, Maxime, Taudon, Nicolas, Morin, François, Magris, Magda, Lacerda, Marcus V G, Viana, Giselle M R, Herrera, Sócrates, Adhin, Malti R, Ferreira, Marcelo U, Woodrow, Charles J, Awab, Ghulam R, Cox, Horace, Ade, Maria-Paz, Mosnier, Emilie, Djossou, Félix, Neafsey, Daniel E, Ringwald, Pascal, Musset, Lise
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/163959
Resumo: Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
id RCAP_950e93aa5c6228440116f69cbc7db331
oai_identifier_str oai:run.unl.pt:10362/163959
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guianaa descriptive epidemiological studymalariaQR MicrobiologyRM Therapeutics. PharmacologyInfectious DiseasesMicrobiology (medical)ParasitologyGeneral Pharmacology, Toxicology and PharmaceuticsEpidemiologySDG 3 - Good Health and Well-beingSDG 10 - Reduced InequalitiesCopyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.BACKGROUND: Plasmodium falciparum is an apicomplexan parasite responsible for lethal cases of malaria. According to WHO recommendations, P falciparum cases are treated with artemisinin-based combination therapy including dihydroartemisinin-piperaquine. However, the emergence of resistant parasites against dihydroartemisinin-piperaquine was reported in southeast Asia in 2008 and, a few years later, suspected in South America. METHODS: To characterise resistance emergence, a treatment efficacy study was performed on the reported patients infected with P falciparum and treated with dihydroartemisinin-piperaquine in French Guiana (n=6, 2016-18). Contemporary isolates collected in French Guiana were genotyped for P falciparum chloroquine resistance transporter (pfCRT; n=845) and pfpm2 and pfpm3 copy number (n=231), phenotyped using the in vitro piperaquine survival assay (n=86), and analysed through genomic studies (n=50). Additional samples from five Amazonian countries and one outside the region were genotyped (n=1440). FINDINGS: In field isolates, 40 (47%) of 86 (95% CI 35·9-57·1) were resistant to piperaquine in vitro; these phenotypes were more associated with pfCRT C350R (ie, Cys350Arg) and pfpm2 and pfpm3 amplifications (Dunn test, p<0·001). Those markers were also associated with dihydroartemisinin-piperaquine treatment failure (n=3 [50%] of 6). A high prevalence of piperaquine resistance markers was observed in Suriname in 19 (83%) of 35 isolates and in Guyana in 579 (73%) of 791 isolates. The pfCRT C350R mutation emerged before pfpm2 and pfpm3 amplification in a temporal sequence different from southeast Asia, and in the absence of artemisinin partial resistance, suggesting a geographically distinctive epistatic relationship between these genetic markers. INTERPRETATION: The high prevalence of piperaquine resistance markers in parasite populations of the Guianas, and the risk of associated therapeutic failures calls for caution on dihydroartemisinin-piperaquine use in the region. Furthermore, greater attention should be given to potential differences in genotype to phenotype mapping across genetically distinct parasite populations from different continents. FUNDING: Pan American Health Organization and WHO, French Ministry for Research, European Commission, Santé publique France, Agence Nationale de la Recherche, Fundação de Amparo à Pesquisa do Estado do Amazonas, Ministry of Health of Brazil, Oswaldo Cruz Foundation, and National Institutes of Health. TRANSLATIONS: For the French and Portuguese translations of the abstract see Supplementary Materials section.Individual Health Care (IHC)Instituto de Higiene e Medicina Tropical (IHMT)Global Health and Tropical Medicine (GHTM)RUNFlorimond, Celiade Laval, FranckEarly, Angela MSauthier, SwaélieLazrek, YassaminePelleau, StéphaneMonteiro, Wuelton MAgranier, MaximeTaudon, NicolasMorin, FrançoisMagris, MagdaLacerda, Marcus V GViana, Giselle M RHerrera, SócratesAdhin, Malti RFerreira, Marcelo UWoodrow, Charles JAwab, Ghulam RCox, HoraceAde, Maria-PazMosnier, EmilieDjossou, FélixNeafsey, Daniel ERingwald, PascalMusset, Lise2024-02-22T23:25:00Z2023-10-162023-10-16T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/163959eng1473-3099PURE: 77161626https://doi.org/10.1016/S1473-3099(23)00502-9info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:49:49Zoai:run.unl.pt:10362/163959Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:59:57.305316Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana
a descriptive epidemiological study
title Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana
spellingShingle Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana
Florimond, Celia
malaria
QR Microbiology
RM Therapeutics. Pharmacology
Infectious Diseases
Microbiology (medical)
Parasitology
General Pharmacology, Toxicology and Pharmaceutics
Epidemiology
SDG 3 - Good Health and Well-being
SDG 10 - Reduced Inequalities
title_short Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana
title_full Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana
title_fullStr Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana
title_full_unstemmed Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana
title_sort Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in French Guiana
author Florimond, Celia
author_facet Florimond, Celia
de Laval, Franck
Early, Angela M
Sauthier, Swaélie
Lazrek, Yassamine
Pelleau, Stéphane
Monteiro, Wuelton M
Agranier, Maxime
Taudon, Nicolas
Morin, François
Magris, Magda
Lacerda, Marcus V G
Viana, Giselle M R
Herrera, Sócrates
Adhin, Malti R
Ferreira, Marcelo U
Woodrow, Charles J
Awab, Ghulam R
Cox, Horace
Ade, Maria-Paz
Mosnier, Emilie
Djossou, Félix
Neafsey, Daniel E
Ringwald, Pascal
Musset, Lise
author_role author
author2 de Laval, Franck
Early, Angela M
Sauthier, Swaélie
Lazrek, Yassamine
Pelleau, Stéphane
Monteiro, Wuelton M
Agranier, Maxime
Taudon, Nicolas
Morin, François
Magris, Magda
Lacerda, Marcus V G
Viana, Giselle M R
Herrera, Sócrates
Adhin, Malti R
Ferreira, Marcelo U
Woodrow, Charles J
Awab, Ghulam R
Cox, Horace
Ade, Maria-Paz
Mosnier, Emilie
Djossou, Félix
Neafsey, Daniel E
Ringwald, Pascal
Musset, Lise
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Individual Health Care (IHC)
Instituto de Higiene e Medicina Tropical (IHMT)
Global Health and Tropical Medicine (GHTM)
RUN
dc.contributor.author.fl_str_mv Florimond, Celia
de Laval, Franck
Early, Angela M
Sauthier, Swaélie
Lazrek, Yassamine
Pelleau, Stéphane
Monteiro, Wuelton M
Agranier, Maxime
Taudon, Nicolas
Morin, François
Magris, Magda
Lacerda, Marcus V G
Viana, Giselle M R
Herrera, Sócrates
Adhin, Malti R
Ferreira, Marcelo U
Woodrow, Charles J
Awab, Ghulam R
Cox, Horace
Ade, Maria-Paz
Mosnier, Emilie
Djossou, Félix
Neafsey, Daniel E
Ringwald, Pascal
Musset, Lise
dc.subject.por.fl_str_mv malaria
QR Microbiology
RM Therapeutics. Pharmacology
Infectious Diseases
Microbiology (medical)
Parasitology
General Pharmacology, Toxicology and Pharmaceutics
Epidemiology
SDG 3 - Good Health and Well-being
SDG 10 - Reduced Inequalities
topic malaria
QR Microbiology
RM Therapeutics. Pharmacology
Infectious Diseases
Microbiology (medical)
Parasitology
General Pharmacology, Toxicology and Pharmaceutics
Epidemiology
SDG 3 - Good Health and Well-being
SDG 10 - Reduced Inequalities
description Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
publishDate 2023
dc.date.none.fl_str_mv 2023-10-16
2023-10-16T00:00:00Z
2024-02-22T23:25:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/163959
url http://hdl.handle.net/10362/163959
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1473-3099
PURE: 77161626
https://doi.org/10.1016/S1473-3099(23)00502-9
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138175889702912